ENZYGNOST ANTI-VZV IGG TEST— 510(k) K863317

Substantially Equivalent

Behring Diagnostics, Inc.

FDA 510(k) clearance K863317 for ENZYGNOST ANTI-VZV IGG TEST, Substantially Equivalent on 1987-04-22. Applicant: Behring Diagnostics, Inc..

Clearance details

Applicant: Behring Diagnostics, Inc.
Product code: Code GQX
Advisory panel: Microbiology
Date received: 1986-08-26
Decision date: 1987-04-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: La Jolla, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.